S. Vieillot

683 total citations
19 papers, 191 citations indexed

About

S. Vieillot is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, S. Vieillot has authored 19 papers receiving a total of 191 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 7 papers in Surgery. Recurrent topics in S. Vieillot's work include Colorectal and Anal Carcinomas (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Colorectal Cancer Surgical Treatments (4 papers). S. Vieillot is often cited by papers focused on Colorectal and Anal Carcinomas (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Colorectal Cancer Surgical Treatments (4 papers). S. Vieillot collaborates with scholars based in France, Monaco and United States. S. Vieillot's co-authors include N. Aillères, D. Azria, P. Fenoglietto, Jean‐Bernard Dubois, C. Lemanski, C. Llacer Moscardo, Sophie Gourgou, O. Riou, I. Barillot and C. Lhommé and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

S. Vieillot

18 papers receiving 187 citations

Peers

Countries citing papers authored by S. Vieillot

Since Specialization

Citations

This map shows the geographic impact of S. Vieillot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Vieillot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Vieillot more than expected).

Fields of papers citing papers by S. Vieillot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Vieillot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Vieillot. The network helps show where S. Vieillot may publish in the future.

Co-authorship network of co-authors of S. Vieillot

This figure shows the co-authorship network connecting the top 25 collaborators of S. Vieillot. A scholar is included among the top collaborators of S. Vieillot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Vieillot. S. Vieillot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study) 2023 ·Targeted Oncology ·(unknown), R. Descourt, (unknown), H. Doubre, C. Decroisette, (unknown), G. Le Garff, L. Falchero, (unknown), S. Vieillot, R. Corre, (unknown), (unknown), L. Bigay-Gamé, Hugues Morel, Olivier Molinier, C. Chouaïd, Florian Guisier	2
2	Three-Year Overall Survival of Patients With Advanced Non–Small-Cell Lung Cancers With ≥50% PD-L1 Expression Treated With First-Line Pembrolizumab Monotherapy in a Real-World Setting (ESCKEYP GFPC Study) 2023 ·Journal of Immunotherapy ·C. Decroisette, Laurent Greillier, (unknown), M. Pérol, Charles Ricordel, J.B. Auliac, L. Falchero, Rémi Veillon, S. Vieillot, Florian Guisier, M. Marcq, (unknown), L. Bigay-Gamé, Massimo Bernardi, H. Doubre, J. Pinsolle, Karim Amrane, C. Chouaïd, R. Descourt	2
3	First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study) 2022 ·Cancer Immunology Immunotherapy ·R. Descourt, Laurent Greillier, M. Pérol, Charles Ricordel, J.B. Auliac, L. Falchero, Radj Gervais, Rémi Veillon, S. Vieillot, Florian Guisier, M. Marcq, (unknown), L. Bigay-Gamé, Massimo Bernardi, P. Fournel, H. Doubre, J. Pinsolle, Karim Amrane, C. Chouaïd, C. Decroisette	18
4	First-line pembrolizumab monotherapy for PD-L1-positive (TPS ≥ 50%) advanced non-small cell lung cancer (aNSCLC) in the real world: A national French bispective multicentric cohort—ESCKEYP trial (GFPC 05-2018). 2021 ·Journal of Clinical Oncology ·R. Descourt, Laurent Greillier, M. Pérol, Charles Ricordel, J.B. Auliac, L. Falchero, (unknown), Rémi Veillon, S. Vieillot, Florian Guisier, M. Marcq, (unknown), Laurence Gamé, Massimo Bernardi, P. Fournel, H. Doubre, J. Pinsolle, Karim Amrane, C. Chouaïd, C. Decroisette	2
5	Phase III randomized study of carboplatin pemetrexed with or without bevacizumab with initial versus “at progression” cerebral radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis 2021 ·Therapeutic Advances in Medical Oncology ·I. Monnet, A. Vergnenègre, G. Robinet, H. Bérard, R. Lamy, L. Falchero, S. Vieillot, Roland Schött, Charles Ricordel, (unknown), P. Thomas, Radj Gervais, Anne Madroszyk, (unknown), (unknown), Laurent Greillier, C. Decroisette, J.B. Auliac, C. Chouaïd, (unknown)	2
6	Long-term follow-up experience in anal canal cancer treated with Intensity-Modulated Radiation Therapy: Clinical outcomes, patterns of relapse and predictors of failure 2019 ·Radiotherapy and Oncology ·(unknown), C. Lemanski, Florence Castan, Emmanuelle Samalin, Thibault Mazard, (unknown), (unknown), O. Riou, C. Llacer-Moscardo, P. Fenoglietto, N. Aillères, Simon Thézenas, (unknown), S. Vieillot, Sophie Gourgou, D. Azria	21
7	Place de l’arcthérapie modulée et de la chimiothérapie concomitante dans la prise en charge des cancers du canal anal localement évolués 2015 ·Cancer/Radiothérapie ·I. Troussier, F. Huguet, S. Servagi-Vernat, (unknown), Jonathan Khalifa, (unknown), Cécile Ortholan, (unknown), C. Dejean, P. Fenoglietto, S. Vieillot, René‐Jean Bensadoun, Juliette Thariat	3
8	IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center 2012 ·Radiation Oncology ·S. Vieillot, P. Fenoglietto, C. Lemanski, C. Llacer Moscardo, Sophie Gourgou, Jean‐Bernard Dubois, N. Aillères, D. Azria	39
9	Bilateral kidney preservation by volumetric-modulated arc therapy (RapidArc) compared to conventional radiation therapy (3D-CRT) in pancreatic and bile duct malignancies 2011 ·Radiation Oncology ·S. Vieillot, D. Azria, O. Riou, C. Llacer Moscardo, Jean‐Bernard Dubois, N. Aillères, P. Fenoglietto	11
10	Radiothérapie postopératoire du cancer de la prostate 2010 ·Cancer/Radiothérapie ·S. Vieillot, P. Fenoglietto, N. Aillères, (unknown), Jean‐Bernard Dubois, D. Azria	2
11	Cancer des sinus de la face 2010 ·Cancer/Radiothérapie ·S. Vieillot, (unknown), N. Aillères, (unknown), Jean‐Bernard Dubois, D. Azria, P. Fénoglietto	3
12	Plan comparison of volumetric-modulated arc therapy (RapidArc) and conventional intensity-modulated radiation therapy (IMRT) in anal canal cancer 2010 ·Radiation Oncology ·S. Vieillot, D. Azria, C. Lemanski, C. Llacer Moscardo, Sophie Gourgou, Jean‐Bernard Dubois, N. Aillères, P. Fenoglietto	59
13	Cancer de la prostate 2010 ·Cancer/Radiothérapie ·S. Vieillot, P. Fenoglietto, N. Aillères, (unknown), Jean‐Bernard Dubois, D. Azria	5
14	Quelle radiothérapie conformationnelle avec modulation d’intensité ? De la technique « step and shoot » à l’arcthérapie, point de vue de l’oncologue radiothérapeute 2010 ·Cancer/Radiothérapie ·S. Vieillot, P. Fénoglietto, C. Llacer Moscardo, N. Aillères, C. Lemanski, Jean‐Bernard Dubois, D. Azria	6
15	Avancées en radiothérapie externe des cancers du sein 2010 ·ONCOLOGIE ·Yazid Belkacémi, A. Tolédano, S. Vieillot, C. Bourgier, D. Azria	0
16	Apport des techniques de curiethérapie optimisée grâce à l’imagerie tridimensionnelle dans la prise en charge des patientes atteintes d’un cancer du col utérin 2009 ·Cancer/Radiothérapie ·Christine Haie-Méder, R. Mazeron, (unknown), (unknown), L Monnier, S. Vieillot, C. Lhommé, Philippe Morice, I. Barillot	12
17	A Planning Study to Compare Plans using Volumetric Modulated Arc Therapy or Intensity-modulated Radiation Therapy for the Treatment of Anal Canal Cancer 2009 ·International Journal of Radiation OncologyBiologyPhysics ·Jean‐Bernard Dubois, S. Vieillot, C. Llacer Moscardo, C. Lemanski, D. Azria, P. Fenoglietto	1
18	Mise en place d’un site Internet d’autoenseignement à la délinéation et à la planification dosimétrique pour les oncologues radiothérapeutes 2008 ·Cancer/Radiothérapie ·Fabrice Denis, Y. Pointreau, S. Vieillot, (unknown), Bernard Fleury, (unknown), Salim Kanoun, D. Azria, I. Barillot, P. Giraud	2
19	Toxicité aiguë de la radiothérapie conformationnelle avec modulation d’intensité dans le traitement des carcinomes épidermoïdes localement évolués du canal anal 2008 ·Cancer/Radiothérapie ·S. Vieillot, P. Fenoglietto, C. Menkarios, N. Aillères, C. Llacer Moscardo, Jean‐Bernard Dubois, C. Lemanski	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact